Form 4: Alphatec Director Keith Valentine Increases Stake in ATEC
Insider Transaction Report
Director Keith Valentine acquired 135,000 shares of Alphatec Holdings, Inc. common stock through open market purchases.
Summary
- Director Keith Valentine purchased a total of 135,000 shares of Alphatec Holdings, Inc. (ATEC) common stock.
- The acquisitions occurred across three separate dates: May 7, May 8, and May 11, 2026.
- The total shares were acquired at prices ranging from $7.00 to $7.55 per share.
- Following these transactions, the director's total beneficial ownership increased to 232,271 shares.
Sentiment
Score: 8
Explanation: StockSavvy.ai views this as a positive signal because significant open-market purchases by a director demonstrate strong conviction in the company's long-term prospects.
Positives
- Strong signal of insider confidence as a director increases their equity position in the company.
- Purchases were made at market prices, indicating a belief in the current valuation of the stock.
Negatives
- None identified.
Risks
- Market volatility affecting the value of the newly acquired shares.
- General risks associated with the medical device industry and regulatory environment.
Future Outlook
Not applicable as this is an insider transaction report.
Industry Context
StockSavvy.ai notes that insider buying is generally viewed as a bullish indicator, suggesting that company leadership sees value in the stock at current price levels, which is particularly relevant in the competitive spine surgery technology sector.
Comparison to Industry Standards
- Insider buying is a standard practice for directors to demonstrate alignment with shareholder interests.
- The volume of shares purchased is significant relative to the director's previous holdings.
Stakeholder Impact
- Shareholders may interpret this as a vote of confidence in the company's strategic direction.
Next Steps
- No future actions or milestones mentioned.
Key Dates
| Date | Description |
|---|---|
| 05/07/2026 | Initial purchase of 56,153 shares at a weighted average price of $7.49. |
| 05/08/2026 | Purchase of 43,847 shares at a weighted average price of $7.54. |
| 05/11/2026 | Final purchase of 35,000 shares at $7.00 per share. |
Recommendation
holdWhile insider buying is a positive signal, it should be considered alongside broader financial performance and market conditions rather than as a standalone reason to buy.
Keywords
Alphatec, ATEC, Insider Trading, Form 4, Medical Devices, Stock Purchase
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.